CYP2E1 and metabolic dysfunction-associated steatohepatitis: Studies have shown that NASH induces cytochrome P450 2E1 (CYP2E1) [72], an enzyme, metabolizing hydrophobic compounds and organic solvents, which include hepatotoxic agents such as CCL4 [74].